Regulation of cyclic adenosine monophosphate release by selective β2-adrenergic receptor stimulation in human terminal failing myocardium before and after ventricular assist device support

被引:2
|
作者
Kassner, Astrid [1 ]
Toischer, Karl [2 ]
Bohms, Birte [1 ]
Kolkhof, Peter [3 ]
Abraham, Getu [4 ]
Hasenfuss, Gerd [2 ]
Morshuis, Michiel [1 ]
Eistrup, Sebastian Schulte [1 ]
El-Banayosy, Aly [1 ]
Gummert, Jan [1 ]
Milting, Hendrik [1 ]
机构
[1] E&H Klessmann Inst Kardiovaskulare Forsch & Ent, Herz & Diabet Zentrum NRW, Klin Thorax & Kardiovaskularchirurg, D-32545 Bad Oeynhausen, Germany
[2] Univ Gottingen, Abt Kardiol, Gottingen, Germany
[3] Bayer Schering Pharma AG, Global Drug Discovery, Wuppertal, Germany
[4] Univ Leipzig, Inst Pharmakol, Fak Vet Med, Leipzig, Germany
来源
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2012年 / 31卷 / 10期
关键词
terminal heart failure; beta(2)-adrenergic receptor signaling; adenylyl cyclase; ventricular assist device; myocardial recovery; acute and chronic heart failure; MECHANICAL CIRCULATORY SUPPORT; STAGE HEART-FAILURE; ADENYLYL-CYCLASE; PHYSIOLOGICAL RELEVANCE; REGIONAL DISTRIBUTION; CARDIAC MYOCYTES; MURINE HEART; CLENBUTEROL; PROTEINS; CARDIOMYOPATHY;
D O I
10.1016/j.healun.2012.07.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Response to catecholamines is blunted in terminal heart failure due to beta-receptor downregulation and uncoupling from adenylyl cyclase (AC). Improved myocardial responsiveness to catecholamines after ventricular assist device (VAD) support is associated with upregulation of beta(1)-adrenergic receptors (beta(1)-ARs). Little is known about the regulation of AC and beta(2)-AR coupling after VAD; moreover beta(2)-AR stimulation during VAD was claimed to induce myocardial recovery. METHODS: We analyzed in VAD-supported human myocardium the regulation of AC activity upon beta(1)-AR and selective beta(2)-AR stimulation in 8 non-failing hearts (NF) and 17 paired samples of VAD patients. AC messenger RNA was measured by TaqMan. AC was stimulated via beta(2)-AR using clenbuterol (beta(2)-AR agonist) and bisoprolol (beta(1)-AR blocker). Organ bath experiments were done with trabeculae from both ventricles. Samples were stratified according to chronic or acute heart failure history. RESULTS: Isoprenaline-induced AC activity was downregulated (p < 0.001) pre-VAD and increased significantly (p < 0.05) after unloading (mean standard deviation pmole/mg/min) in NF (47.9 +/- 14.9), pre-VAD (24.35 +/- 13.3), and post-VAD (50.04 +/- 50.25). Forskolin stimulation revealed significant (p < 0.05) upregulation of AC activity during VAD, especially in acutely failing hearts (NF, 192.1 +/- 68.7; pre-VAD, 191.1 +/- 60.4; post-VAD, 281.5 +/- 133). However, forskolin stimulation relative to isoprenaline-induced inotropy remained reduced before and after VAD compared with NF. The selective stimulation of beta(2)-AR did not reveal influence of VAD support on beta(2)-AR-AC coupling. Stimulation of ventricular trabeculae by > 100 mu mole/liter clenbuterol revealed negative inotropic responses. CONCLUSIONS: VAD does not influence beta(2)-AR coupling to AC stimulation. Elevated response to catecholamines after VAD support is influenced by beta(1)-AR upregulation and modulation of AC activity. Restoration of beta-adrenergic responsiveness was restricted to acutely failing hearts. J Heart Lung Transplant 2012;31:1127-35 (C) 2012 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:1127 / 1135
页数:9
相关论文
共 14 条
  • [1] Effects of milrinone on contractility and cyclic adenosine monophosphate production induced by β1- and β2-adrenergic receptor activation in human myocardium
    Carceles, Maria D.
    Fuentes, Teodomiro
    Aroca, Vicente
    Lopez, Jesus
    Hernandez, Jesus
    CLINICAL THERAPEUTICS, 2007, 29 (08) : 1718 - 1724
  • [2] Activity of the Akt/GSK-3β pathway in the failing human heart before and after left ventricular assist device support
    Razeghi, P
    Taegtmeyer, H
    CARDIOVASCULAR RESEARCH, 2004, 61 (01) : 196 - 197
  • [3] Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart
    Chaudhary, KW
    Rossman, EI
    Piacentino, V
    Kenessey, A
    Weber, C
    Gaughan, JP
    Ojamaa, K
    Klein, I
    Bers, DM
    Houser, SR
    Margulies, KB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (04) : 837 - 845
  • [4] Inflammation Mediated Fibrosis Is Regulated Through Distinct Gene-Gene Co-Expression Networks in the Failing Human Myocardium Before and After Left Ventricular Assist Device Support
    Topkara, V. K.
    Godier-Furnemont, A.
    Bax, N.
    Fine, B.
    Garan, A.
    Yuzefpolskaya, M.
    Takeda, K.
    Takayama, H.
    Naka, Y.
    Mancini, D.
    Colombo, P. C.
    Jorde, U. P.
    Vunjak-Novakovic, G.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S212 - S212
  • [5] Role of α2-adrenergic receptors and cyclic adenosine monophosphate-dependent protein kinase in the regulation of norepinephrine release in the central nervous system of spontaneously hypertensive rats
    Tsuda, K
    Tsuda, S
    Nishio, I
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 42 : S81 - S85
  • [6] BETA-1-ADRENERGIC AND BETA-2-ADRENERGIC RECEPTOR-MEDIATED ADENYLATE-CYCLASE STIMULATION IN NONFAILING AND FAILING HUMAN VENTRICULAR MYOCARDIUM
    BRISTOW, MR
    HERSHBERGER, RE
    PORT, JD
    MINOBE, W
    RASMUSSEN, R
    MOLECULAR PHARMACOLOGY, 1989, 35 (03) : 295 - 303
  • [7] Apoptosis and expression of PCNA and bcl-2 in failing human hearts before and after the implantation of a left ventricular assist device (LVAD).
    Anwar, F
    Banks, A
    Kubo, S
    Francis, G
    Jessurun, J
    MODERN PATHOLOGY, 1998, 11 (01) : 32A - 32A
  • [8] Alterations in Ca2+ cycling proteins and Gag signaling after left ventricular assist device support in failing human hearts
    Takeishi, Y
    Jalili, T
    Hoit, BD
    Kirkpatrick, DL
    Wagoner, LE
    Abraham, WT
    Walsh, RA
    CARDIOVASCULAR RESEARCH, 2000, 45 (04) : 883 - 888
  • [9] THE EFFECT OF A SELECTIVE ALPHA-2-ADRENERGIC RECEPTOR ANTAGONIST (MIDAGLIZOLE) ON THE CYCLIC 3',5'-ADENOSINE-MONOPHOSPHATE PRODUCTION IN HUMAN MONONUCLEAR-CELLS
    SUGIYAMA, H
    MIYAGAWA, H
    OKADA, C
    HOPP, RJ
    BEWTRA, AK
    TOWNLEY, RG
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (03) : 722 - 729
  • [10] Differential alterations in Ca2+ cycling and Gαq signaling proteins after left ventricular assist device support in failing human hearts
    Takeishi, Y
    Jalili, T
    Kirkpatrick, DL
    Wagoner, LE
    Abraham, WT
    Walsh, RA
    CIRCULATION, 1999, 100 (18) : 419 - 419